The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Leif Groop

Leif Groop

Principal investigator

Leif Groop

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174GC with circulating glucose levels, interleukin-6 levels, and body mass index


  • Cornelia Huth
  • Thomas Illig
  • Christian Herder
  • Christian Gieger
  • Harald Grallert
  • Caren Vollmert
  • Wolfgang Rathmann
  • Yasmin H. Hamid
  • Oluf Pedersen
  • Torben Hansen
  • Barbara Thorand
  • Christa Meisinger
  • Angela Doering
  • Norman Klopp
  • Henning Gohlke
  • Wolfgang Lieb
  • Christian Hengstenberg
  • Valeriya Lyssenko
  • Leif Groop
  • Helen Ireland
  • Jeffrey W. Stephens
  • Ingrid Wernstedt Asterholm
  • John-Olov Jansson
  • Heiner Boeing
  • Matthias Moehlig
  • Heather M. Stringham
  • Michael Boehnke
  • Jaakko Tuomilehto
  • Jose-Manuel Fernandez-Real
  • Abel Lopez-Bermejo
  • Luis Gallart
  • Joan Vendrell
  • Steve E. Humphries
  • Florian Kronenberg
  • H. -Erich Wichmann
  • Iris M. Heid

Summary, in English

Background. Several studies have investigated associations between the -174GC single nucleotide polymorphism (rs1800795) of the IL6 gene and phenotypes related to type 2 diabetes mellitus (T2DM) but presented inconsistent results. Aims. This joint analysis aimed to clarify whether IL6 -174GC was associated with glucose and circulating interleukin-6 concentrations as well as body mass index (BMI). Methods. Individual-level data from all studies of the IL6-T2DM consortium on Caucasian subjects with available BMI were collected. As study-specific estimates did not show heterogeneity (P0.1), they were combined by using the inverse-variance fixed-effect model. Results. The main analysis included 9440, 7398, 24,117, or 5659 non-diabetic and manifest T2DM subjects for fasting glucose, 2-hour glucose, BMI, or circulating interleukin-6 levels, respectively. IL6 -174 C-allele carriers had significantly lower fasting glucose (-0.091 mmol/L, P=0.014). There was no evidence for association between IL6 -174GC and BMI or interleukin-6 levels, except in some subgroups. Conclusions. Our data suggest that C-allele carriers of the IL6 -174GC polymorphism have lower fasting glucose levels on average, which substantiates previous findings of decreased T2DM risk of these subjects.


  • Genomics, Diabetes and Endocrinology

Publishing year







Annals of Medicine





Document type

Journal article


Taylor & Francis


  • Endocrinology and Diabetes


  • meta-analysis
  • molecular epidemiology
  • single nucleotide polymorphism
  • intermediate phenotype
  • interleukin-6
  • inflammation mediators
  • genes
  • diabetes mellitus type 2
  • Blood glucose
  • body mass index



Research group

  • Genomics, Diabetes and Endocrinology


  • ISSN: 1365-2060